Abstract
Klebsiella pneumoniae is a Gram-negative pathogen capable of causing a diverse array of infections in humans. It belongs to the group of ESKAPE pathogens, which are responsible for causing severe infections in immunocompromised individuals. The virulence of K. pneumoniae is attributed to several factors, including the synthesis of capsular polysaccharides, lipopolysaccharides, fimbriae, and iron acquisition systems. Additionally, K. pneumoniae can form a biofilm, which protects it from both host immune defense and antimicrobial agents. Its ability to form biofilm thus adds to its virulence potential significantly as biofilm-associated infections are notoriously difficult to treat. Thus, the chapter has been designed to provide an overview on the synthesis, structure, and function of virulence factors and biofilm components of K. pneumoniae, which contribute to its pathogenicity and also its multidrug resistance (MDR). Furthermore, the chapter discusses the various inhibitors developed to target these virulence factors and biofilm components, which can potentially be used as therapeutic agents to combat infections caused by K. pneumoniae.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adonizio AL (2008) Anti-quorum sensing agents from South Florida medicinal plants and their attenuation of Pseudomonas aeruginosa pathogenicity. Doctoral dissertation, Florida International University
Álvarez D, Merino S, TomÁs JM, Benedí VJ, Albertí S (2000) Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical isolates. Infect Immun 68(2):953–955
Allen IC, McElvania-TeKippe E, Wilson JE, Lich JD, Arthur JC, Sullivan JT et al (2013) Characterization of NLRP12 during the in vivo host immune response to Klebsiella pneumoniae and Mycobacterium tuberculosis. PloS one 8(4):e60842. https://doi.org/10.1371/journal.pone.0060842
Bachman MA, Oyler JE, Burns SH, Caza M, Lépine F, Dozois CM, Weiser JN (2011) Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect Immun 79(8):3309–3316
Barraud N, Kelso MJ, Rice SA, Kjelleberg S (2015) Nitric oxide: a key mediator of biofilm dispersal with applications in infectious diseases. Curr Pharm Des 21(1):31–42
Bassetti MATTEO, Giacobbe DR, Giamarellou H, Viscoli C, Daikos GL, Dimopoulos G, Poulakou G (2018) Management of KPC-producing Klebsiella pneumoniae infections. Clin Microbiol Infect 24(2):133–144
Bengoechea JA, Sa Pessoa J (2019) Klebsiella pneumoniae infection biology: living to counteract host defences. FEMS Microbiol Rev 43(2):123–144
Bossuet-Greif N, Dubois D, Petit C, Tronnet S, Martin P, Bonnet R et al (2016) Escherichia coli ClbS is a colibactin resistance protein. Mol Microbiol 99(5):897–908. https://doi.org/10.1111/mmi.13272
Campos MA, Vargas MA, Regueiro V, Llompart CM, Albertí S, Bengoechea JA (2004) Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun 72(12):7107–7114
Cano V, March C, Insua JL, Aguiló N, Llobet E, Moranta D, Bengoechea JA (2015) Klebsiella pneumoniae survives within macrophages by avoiding delivery to lysosomes. Cell Microbiol 17(11):1537–1560
Cesur MF, Siraj B, Uddin R, Durmuş S, Çakır T (2020) Network-based metabolism-centered screening of potential drug targets in Klebsiella pneumoniae at genome scale. Front Cell Infect Microbiol 9:447
Chang D, Sharma L, Dela Cruz CS, Zhang D (2021) Clinical epidemiology, risk factors, and control strategies of Klebsiella pneumoniae infection. Front Microbiol 12:750662
Choby JE, Howard-Anderson J, Weiss DS (2020) Hypervirulent Klebsiella pneumoniae—clinical and molecular perspectives. J Intern Med 287(3):283–300
Clarke BR, Ovchinnikova OG, Kelly SD, Williamson ML, Butler JE, Liu B et al (2018) Molecular basis for the structural diversity in serogroup O2-antigen polysaccharides in Klebsiella pneumoniae. J Biol Chem 293(13):4666–4679. https://doi.org/10.1074/jbc.RA117.000646
Cortés G, Borrell N, de Astorza B, Gómez C, Sauleda J, Albertí S (2002) Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect Immun 70(5):2583–2590
Cryz SJ Jr, Fürer E, Germanier R (1985) Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans. J Infect Dis 151(4):665–671
De Araujo C, Balestrino D, Roth L, Charbonnel N, Forestier C (2010) Quorum sensing affects biofilm formation through lipopolysaccharide synthesis in Klebsiella pneumoniae. Res Microbiol 161(7):595–603
de Astorza B, Cortés G, Crespí C, Saus C, Rojo JM, Albertí S (2004) C3 promotes clearance of Klebsiella pneumoniae by A549 epithelial cells. Infect Immun 72(3):1767–1774
Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Triplicane Dwarakanathan H, Murugan D, Umashankar Y, Monk PN, Veeraraghavan B (2020) The influence of biofilms on carbapenem susceptibility and patient outcome in device associated K. pneumoniae infections: insights into phenotype vs genome-wide analysis and correlation. Front Microbiol 11:591679
Dong N, Yang X, Chan EWC, Zhang R, Chen S (2022) Klebsiella species: taxonomy, hypervirulence and multidrug resistance. EBioMedicine 79:103998
Doorduijn DJ, Rooijakkers SH, van Schaik W, Bardoel BW (2016) Complement resistance mechanisms of Klebsiella pneumoniae. Immunobiology 221(10):1102–1109
dos Santos Goncalves M, Delattre C, Balestrino D, Charbonnel N, Elboutachfaiti R, Wadouachi A et al (2014) Anti-biofilm activity: a function of Klebsiella pneumoniae capsular polysaccharide. PLoS One 9(6):e99995. https://doi.org/10.1371/journal.pone.0099995
Dziubańska-Kusibab PJ, Berger H, Battistini F, Bouwman BA, Iftekhar A, Katainen R, Meyer TF (2020) Colibactin DNA-damage signature indicates mutational impact in colorectal cancer. Nat Med 26(7):1063–1069
Evrard B, Balestrino D, Dosgilbert A, Bouya-Gachancard JL, Charbonnel N, Forestier C, Tridon A (2010) Roles of capsule and lipopolysaccharide O antigen in interactions of human monocyte-derived dendritic cells and Klebsiella pneumoniae. Infect Immun 78(1):210–219
Ferry T, Boucher F, Fevre C, Perpoint T, Chateau J, Petitjean C, Laurent F (2018) Innovations for the treatment of a complex bone and joint infection due to XDR Pseudomonas aeruginosa including local application of a selected cocktail of bacteriophages. J Antimicrob Chemother 73(10):2901–2903
Foerster J, Bachman M (2015) Beyond passive immunization: toward a nanoparticle-based IL-17 vaccine as first in class of future immune treatments. Nanomedicine 10(8):1361–1369
Follador R, Heinz E, Wyres KL, Ellington MJ, Kowarik M, Holt KE, Thomson NR (2016) The diversity of Klebsiella pneumoniae surface polysaccharides. Microb Genom 2(8). https://doi.org/10.1099/mgen.0.000073
Frank CG, Reguerio V, Rother M, Moranta D, Maeurer AP, Garmendia J, Bengoechea JA (2013) Klebsiella pneumoniae targets an EGF receptor-dependent pathway to subvert inflammation. Cell Microbiol 15(7):1212–1233
Gerlach GF, Clegg STEVEN, Allen B (1989) Identification and characterization of the genes encoding the type 3 and type 1 fimbrial adhesins of Klebsiella pneumoniae. J Bacteriol 171(3):1262–1270. https://doi.org/10.1128/jb.171.3.1262-1270.1989
Galdiero E, Salvatore MM, Maione A, Carraturo F, Galdiero S, Falanga A et al (2021) Impact of the peptide WMR-K on dual-Species biofilm Candida albicans/Klebsiella pneumoniae and on the untargeted metabolomic profile. Pathogens 10(2):214. https://doi.org/10.3390/pathogens10020214
Gomes AÉI, Pacheco T, Santos CDSD, Pereira JA, Ribeiro ML, Darrieux M, Ferraz LFC (2021) Functional insights from KpfR, a new transcriptional regulator of fimbrial expression that is crucial for Klebsiella pneumoniae pathogenicity. Front Microbiol 11:601921
Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, Standiford TJ (1995) Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol (Baltimore, Md.: 1950) 155(2):722–729
Guan S, Clarke AJ, Whitfield C (2001) Functional analysis of the galactosyltransferases required for biosynthesis of D-galactan I, a component of the lipopolysaccharide O1 antigen of Klebsiella pneumoniae. J Bacteriol 183(11):3318–3327
Guerra MES, Destro G, Vieira B, Lima AS, Ferraz LFC, Hakansson AP, Converso TR (2022) Klebsiella pneumoniae biofilms and their role in disease pathogenesis. Front Cell Infect Microbiol 12:877995
Held TK, Trautmann M, Mielke ME, Neudeck H, Cryz SJ Jr, Cross AS (1992) Monoclonal antibody against Klebsiella capsular polysaccharide reduces severity and hematogenic spread of experimental Klebsiella pneumoniae pneumonia. Infect Immun 60(5):1771–1778
Hernandez-Delgadillo R, Velasco-Arias D, Diaz D, Arevalo-Niño K, Garza-Enriquez M, De la Garza-Ramos MA, Cabral-Romero C (2012) Zerovalent bismuth nanoparticles inhibit Streptococcus mutans growth and formation of biofilm. Int J Nanomedicine 7:2109–2113
Holden VI, Breen P, Houle S, Dozois CM, Bachman MA (2016) Klebsiella pneumoniae siderophores induce inflammation, bacterial dissemination, and HIF-1α stabilization during pneumonia. MBio 7(5):10–1128
Huang X, Li X, An H, Wang J, Ding M, Wang L, Zhang JR (2022) Capsule type defines the capability of Klebsiella pneumoniae in evading Kupffer cell capture in the liver. PLoS Pathog 18(8):e1010693
Jadimurthy R, Mayegowda SB, Nayak SC, Mohan CD, Rangappa KS (2022) Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds. Biotechnol Rep 34:e00728
Kabha KISRA, Schmegner JUTTA, Keisari YONA, Parolis HARALAMBOS, Schlepper-Schaeffer J, Ofek ITZHAK (1997) SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages. Am J Phys Lung Cell Mol Phys 272(2):L344–L352
Karampatakis T, Tsergouli K, Behzadi P (2023) Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics 12(2):234
Kidd TJ, Mills G, Sá-Pessoa J, Dumigan A, Frank CG, Insua JL, Bengoechea JA (2017) A Klebsiella pneumoniae antibiotic resistance mechanism that subdues host defences and promotes virulence. EMBO Mol Med 9(4):430–447
Kostina E, Ofek I, Crouch E, Friedman R, Sirota L, Klinger G, Keisari Y (2005) Noncapsulated Klebsiella pneumoniae bearing mannose-containing O antigens is rapidly eradicated from mouse lung and triggers cytokine production by macrophages following opsonization with surfactant protein D. Infect Immun 73(12):8282–8290
Kot B, Piechota M, Szweda P, Mitrus J, Wicha J, Grużewska A, Witeska M (2023) Virulence analysis and antibiotic resistance of Klebsiella pneumoniae isolates from hospitalised patients in Poland. Sci Rep 13(1):4448
Lamey AE, Selim AO, Atia NM, Mowafy RE (2023) Genes contributed on biofilm forming bacteria incriminated in various disease conditions in cattle. J Adv Vet Res 13(3):312–321
Lawlor MS, Hsu J, Rick PD, Miller VL (2005) Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model. Mol Microbiol 58(4):1054–1073
Lawlor MS, O’connor C, Miller VL (2007) Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection. Infect Immun 75(3):1463–1472
Lee K, Yoon SS (2017) Pseudomonas aeruginosa biofilm, a programmed bacterial life for fitness. J Microbiol Biotechnol 27(6):1053–1064
Li B, Zhao Y, Liu C, Chen Z, Zhou D (2014) Molecular pathogenesis of Klebsiella pneumoniae. Future Microbiol 9(9):1071–1081
Llobet E, Campos MA, Giménez P, Moranta D, Bengoechea JA (2011) Analysis of the networks controlling the antimicrobial-peptide-dependent induction of Klebsiella pneumoniae virulence factors. Infect Immun 79(9):3718–3732
Mahrous SH, El-Balkemy FA, Abo-Zeid NZ, El-Mekkawy MF, El Damaty HM, Elsohaby I (2023) Antibacterial and anti-biofilm activities of Cinnamon Oil against multidrug-resistant Klebsiella pneumoniae isolated from Pneumonic Sheep and Goats. Pathogens 12(9):1138. https://doi.org/10.3390/pathogens12091138
Mannes GP, Boersma WG, Baur CH, Postmus PE (1991) Adult respiratory distress syndrome (ARDS) due to bacteraemic pneumococcal pneumonia. Eur Respir J 4(4):503–504
March C, Moranta D, Regueiro V, Llobet E, Tomás A, Garmendia J, Bengoechea JA (2011) Klebsiella pneumoniae outer membrane protein A is required to prevent the activation of airway epithelial cells. J Biol Chem 286(12):9956–9967
Merino S, Camprubí S, Albertí S, Benedí VJ, Tomas J (1992) Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing. Infect Immun 60(6):2529–2535
Miller MB, Bassler BL (2001) Quorum sensing in bacteria. Annu Rev Microbiol 55(1):165–199
Mills G, Dumigan A, Kidd T, Hobley L, Bengoechea JA (2017) Identification and characterization of two Klebsiella pneumoniae lpxL lipid A late acyltransferases and their role in virulence. Infect Immun 85(9):10–1128
Mirzaei B, Ebrahimi A, Keshavarzi S, Hydarzadeh S, Badmasti F, Dadar M, Moradi N (2023) Antibiotic susceptibility, biofilm-forming ability, and prevalence of extended-spectrum beta-lactamase (ESBL)-and biofilm-associated genes among Klebsiella pneumoniae isolates from hospitalized patients in northwest of Iran. Curr Microbiol 80(5):175
Nougayrède JP, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, Oswald E (2006) Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313(5788):848–851
Ofek I, Mesika A, Kalina M, Keisari Y, Podschun R, Sahly H, Crouch E (2001) Surfactant protein D enhances phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniae. Infect Immun 69(1):24–33
Opoku-Temeng C, Kobayashi SD, DeLeo FR (2019) Klebsiella pneumoniae capsule polysaccharide as a target for therapeutics and vaccines. Comput Struct Biotechnol J 17:1360–1366
Pacheco T, Gomes AÉI, Siqueira NMG, Assoni L, Darrieux M, Venter H, Ferraz LFC (2021) SdiA, a quorum-sensing regulator, suppresses fimbriae expression, biofilm formation, and quorum-sensing signaling molecules production in. Front Microbiol 12:597735
Packiavathy IASV, Kannappan A, Thiyagarajan S, Srinivasan R, Jeyapragash D, Paul JBJ, Ravi AV (2021) AHL-Lactonase producing Psychrobacter sp. from Palk Bay sediment mitigates quorum sensing-mediated virulence production in Gram negative bacterial pathogens. Front Microbiol 12:634593
Paczosa MK, Mecsas J (2016) Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev 80(3):629–661
Padilla E, Llobet E, Doménech-Sánchez A, Martínez-Martínez L, Bengoechea JA, Albertí S (2010) Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob Agents Chemother 54(1):177–183
Pan YJ, Lin TL, Hsu CR, Wang JT (2011) Use of a Dictyostelium model for isolation of genetic loci associated with phagocytosis and virulence in Klebsiella pneumoniae. Infect Immun 79(3):997–1006
Patro LPP, Rathinavelan T (2019) Targeting the sugary armor of Klebsiella species. Front Cell Infect Microbiol 9:367
Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11(4):589–603
Pranavathiyani G, Prava J, Rajeev AC, Pan A (2020) Novel target exploration from hypothetical proteins of Klebsiella pneumoniae MGH 78578 reveals a protein involved in host-pathogen interaction. Front Cell Infect Microbiol 10:109
Rahn A, Drummelsmith J, Whitfield C (1999) Conserved organization in the cps gene clusters for expression of Escherichia coli group 1 K antigens: relationship to the colanic acid biosynthesis locus and the cps genes from Klebsiella pneumoniae. J Bacteriol 181(7):2307–2313. https://doi.org/10.1128/JB.181.7.2307-2313.1999
Rammaert B, Goyet S, Beauté J, Hem S, Te V, Try PL, Vong S (2012) Klebsiella pneumoniae related community-acquired acute lower respiratory infections in Cambodia: clinical characteristics and treatment. BMC Infect Dis 12(1):1–7
Rasmussen TB, Bjarnsholt T, Skindersoe ME, Hentzer M, Kristoffersen P, Kote M, Givskov M (2005) Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector. J Bacteriol 187(5):1799–1814
Regueiro V, Campos MA, Pons J, Albertí S, Bengoechea JA (2006) The uptake of a Klebsiella pneumoniae capsule polysaccharide mutant triggers an inflammatory response by human airway epithelial cells. Microbiology 152(2):555–566
Regueiro V, Moranta D, Frank CG, Larrarte E, Margareto J, March C, Bengoechea JA (2011) Klebsiella pneumoniae subverts the activation of inflammatory responses in a NOD1-dependent manner. Cell Microbiol 13(1):135–153
Rendueles O, Beloin C, Latour-Lambert P, Ghigo JM (2014) A new biofilm-associated colicin with increased efficiency against biofilm bacteria. ISME J 8(6):1275–1288
Rifaat RM, Ghaima KK (2023) Detection of type1 fimbriae genes (fimH and fimA) of Klebsiella pneumoniae among Iraqi Patients with catheter-associated urinary tract infections. Acta Biomed 94(2):e2023064
Riwu KHP, Effendi MH, Rantam FA, Khairullah AR, Widodo A (2022) A review: virulence factors of Klebsiella pneumonia as emerging infection on the food chain. Vet World 15(9):2172
Russo TA, Marr CM (2019) Hypervirulent Klebsiella pneumoniae. Clin Microbiol Rev 32(3):10–1128
Russo TA, Shon AS, Beanan JM, Olson R, MacDonald U, Pomakov AO, Visitacion MP (2011) Hypervirulent K. pneumoniae secretes more and more active iron-acquisition molecules than “classical” K. pneumoniae thereby enhancing its virulence. PLoS One 6(10):e26734
Rutherford ST, Bassler BL (2012) Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med 2(11):a012427
Sachdeva S, Palur RV, Sudhakar KU, Rathinavelan T (2017) E. coli group 1 capsular polysaccharide exportation nanomachinary as a plausible antivirulence target in the perspective of emerging antimicrobial resistance. Front Microbiol 8:70. https://doi.org/10.3389/fmicb.2017.00070
Santajit S, Indrawattana N (2016) Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int 2016:2475067
Santos PBDRED, Avila DDS, Ramos LDP, Yu AR, Santos CEDR, Berretta AA, Oliveira LDD (2020) Effects of Brazilian green propolis extract on planktonic cells and biofilms of multidrug-resistant strains of Klebsiella pneumoniae and Pseudomonas aeruginosa. Biofouling 36(7):834–845
Shadkam S, Goli HR, Mirzaei B, Gholami M, Ahanjan M (2021) Correlation between antimicrobial resistance and biofilm formation capability among Klebsiella pneumoniae strains isolated from hospitalized patients in Iran. Ann Clin Microbiol Antimicrob 20:1–7
Shen L, Zhang J, Xue J, Du L, Yuan L, Nie H, Li Y (2022) Regulation of ECP fimbriae-related genes by the transcriptional regulator RcsAB in Klebsiella pneumoniae NTUH-K2044. J Basic Microbiol 62(5):593–603
Shon AS, Bajwa RP, Russo TA (2013) Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 4(2):107–118
Standiford TJ, Wilkowski JM, Sisson TH, Hattori N, Mehrad B, Bucknell KA, Moore TA (1999) Intrapulmonary tumor necrosis factor gene therapy increases bacterial clearance and survival in murine gram-negative pneumonia. Hum Gene Ther 10(6):899–909
Strakova N, Korena K, Karpiskova R (2021) Klebsiella pneumoniae producing bacterial toxin colibactin as a risk of colorectal cancer development—a systematic review. Toxicon 197:126–135
Swati S (2016) A study on microbiological profile of symptomatic catheter associated urinary tract infection in an intensive care unit setup in a Tertiary care hospital. Doctoral dissertation, Madras Medical College, Chennai
Tacconelli E (2017) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development. WHO pp 1–7. https://policycommons.net/artifacts/1818147/global-priority-list-of-antibiotic-resistant-bacteria-to-guide-researchdiscovery-and-development/2555608/
Tängdén T, Hickman RA, Forsberg P, Lagerbäck P, Giske CG, Cars O (2014) Evaluation of double-and triple-antibiotic combinations for VIM-and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments. Antimicrob Agents Chemother 58(3):1757–1762
Tesfa T, Mitiku H, Edae M, Assefa N (2022) Prevalence and incidence of carbapenem-resistant K. pneumoniae colonization: systematic review and meta-analysis. Syst Rev 11(1):1–15
Thorpe HA, Booton R, Kallonen T, Gibbon MJ, Couto N, Passet V, Feil EJ (2022) A large-scale genomic snapshot of Klebsiella spp. isolates in Northern Italy reveals limited transmission between clinical and non-clinical settings. Nat Microbiol 7(12):2054–2067
Tomás A, Lery L, Regueiro V, Pérez-Gutiérrez C, Martínez V, Moranta D, Bengoechea JA (2015) Functional genomic screen identifies Klebsiella pneumoniae factors implicated in blocking nuclear factor κB (NF-κB) signaling. J Biol Chem 290(27):16678–16697
Tsai CC, Lin JC, Chen PC, Liu EYM, Tsai YK, Yu CP, Siu LK (2023) A 20-year study of capsular polysaccharide seroepidemiology, susceptibility profiles, and virulence determinants of Klebsiella pneumoniae from bacteremia patients in Taiwan. Microbiol Spectr 11(3):e00359–e00323
Venkitapathi S, Wijesundara YH, Cornelius SA, Herbert FC, Gassensmith JJ, Zimmern PE, De Nisco NJ (2022) Conserved FimK truncation coincides with increased expression of type 3 fimbriae and cultured bladder epithelial cell association in Klebsiella quasipneumoniae. J Bacteriol 204(9):e00172–e00122
Vuotto C, Longo F, Pascolini C, Donelli G, Balice MP, Libori MF et al (2017) Biofilm formation and antibiotic resistance in Klebsiella pneumoniae urinary strains. J Appl Microbiol 123(4):1003–1018. https://doi.org/10.1111/jam.13533
Wand ME, McCowen JW, Nugent PG, Sutton JM (2013) Complex interactions of Klebsiella pneumoniae with the host immune system in a Galleria mellonella infection model. J Med Microbiol 62(12):1790–1798
Wang G, Zhao G, Chao X, Xie L, Wang H (2020) The characteristic of virulence, biofilm and antibiotic resistance of Klebsiella pneumoniae. Int J Environ Res Public Health 17(17):6278
Wei DD, Xiong XS, Mei YF, Du FL, Wan LG, Liu Y (2021) Microbiological and clinical characteristics of Klebsiella pneumoniae isolates of K57 capsular serotype in China. Microb Drug Resist 27(3):391–400
Whitfield C, Paiment A (2003) Biosynthesis and assembly of Group 1 capsular polysaccharides in Escherichia coli and related extracellular polysaccharides in other bacteria. Carbohydr Res 338(23):2491–2502
Willingham SB, Allen IC, Bergstralh DT, Brickey WJ, Huang MTH, Taxman DJ, Ting JPY (2009) NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and-independent pathways. J Immunol 183(3):2008–2015
Wu CC, Lin CT, Cheng WY, Huang CJ, Wang ZC, Peng HL (2012) Fur-dependent MrkHI regulation of type 3 fimbriae in Klebsiella pneumoniae CG43. Microbiology 158(4):1045–1056. https://doi.org/10.1099/mic.0.053801-0
Wu C-C, Wang C-K, Chen Y-C, Lin T-H, Jinn T-R, Lin C-T (2014) IscR regulation of capsular polysaccharide biosynthesis and iron-acquisition systems in klebsiella pneumoniae CG43. PLoS ONE 9(9):e107812. https://doi.org/10.1371/journal.pone.0107812
Xiao X, Yeoh BS, Vijay-Kumar M (2017) Lipocalin 2: an emerging player in iron homeostasis and inflammation. Annu Rev Nutr 37:103–130
Yang MT (1974) Structural studies of Klebsiella capsular polysaccharides. Doctoral dissertation, University of British Columbia
Yoshida K, Matsumoto T, Tateda K, Uchida K, Tsujimoto S, Iwakura Y, Yamaguchi K (2001) Protection against pulmonary infection with Klebsiella pneumoniae in mice by interferon-γ through activation of phagocytic cells and stimulation of production of other cytokines. J Med Microbiol 50(11):959–964
Yu HH, Zhang L, Yu F, Li F, Liu ZY, Chen JH (2017) Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin. Materials 10(2):183
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Joseph, B.J., Mathew, M., Rachel, R., Mathew, J., Radhakrishnan, E.K. (2024). Klebsiella pneumoniae Virulence Factors and Biofilm Components: Synthesis, Structure, Function, and Inhibitors. In: Busi, S., Prasad, R. (eds) ESKAPE Pathogens. Springer, Singapore. https://doi.org/10.1007/978-981-99-8799-3_9
Download citation
DOI: https://doi.org/10.1007/978-981-99-8799-3_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-8798-6
Online ISBN: 978-981-99-8799-3
eBook Packages: MedicineMedicine (R0)